medwireNews

Our team consists of skilled and committed news writers who have extensive experience and a strong foundation in science, allowing us to effectively communicate medical news.

International, Trade/B2B

English

Newswire/News Agency

Outlet metrics

Domain Authority

Ranking

Global

#3780483

United States

#1027442

Health/Health

#14677

Traffic sources

Monthly visitors

Articles

Polygenic risk score may improve prostate cancer screening

1 week ago | medwirenews.com | Lucy Piper

medwireNews: A polygenic risk score could help direct prostate cancer screening towards those at highest risk for the disease, the BARCODE1 investigators report. This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France. Read the full story on the L’Institut Servier websiteImage credit: © angellodeco / stock.adobe.com
CSF tau may flag hippocampal atrophy in new-onset refractory status epilepticus

2 weeks ago | medwirenews.com | Lucy Piper

By Lucy Piper, medwireNews ReportermedwireNews: Elevated total tau in cerebral spinal fluid may indicate initial brain injury in patients with cryptogenic new-onset refractory status epilepticus and predict subsequent hippocampal atrophy, suggest study findings. This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.
Intensive systolic blood pressure control reduces CVD mortality risk in the over 80s

3 weeks ago | medwirenews.com | Lucy Piper

By Lucy Piper, medwireNews ReportermedwireNews: Antihypertensive treatment of patients over the age of 80 years to a target systolic blood pressure below 130 mmHg could significantly reduce their risk of death from cardiovascular disease by 26%, suggests an analysis of NHANES data. This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France. Read the full story on the L’Institut Servier websiteImage credit: © Drazen Zigic / Getty Images / iStock
Half-dose apixaban noninferior for preventing recurrent VTE in cancer patients

1 month ago | medwirenews.com | Lynda Williams |Lucy Piper

By Lynda Williams, medwireNews ReportermedwireNews: For patients with active cancer and venous thromboembolism, a reduced dose of apixaban is noninferior to the standard dose for preventing recurrent thromboembolic episodes and significantly reduces the risk of clinically relevant bleeding, report the API-CAT investigators. This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.
‘Accelerated’ onset of aging-related disease highlighted for childhood cancer survivors

1 month ago | medwirenews.com | Lynda Williams |Lucy Piper

By Lynda Williams, medwireNews ReportermedwireNews: Children who survive for at least 5 years after treatment for cancer are 2.7 times more likely to develop one of eight aging-related chronic health conditions before the age of 65 years than members of the general population, US researchers suggest. This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.
Chemoprevention use after TNBC ‘may be reasonable’

1 month ago | medwirenews.com | Lynda Williams |Lucy Piper

By Lynda Williams, medwireNews ReportermedwireNews: Research indicates that women with triple-negative breast cancer might benefit from low-dose tamoxifen to reduce the risk of recurrent or new primary disease. This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France. Read the full story on the L’Institut Servier websiteImage credit: © Crystal light / Stock.adobe.com
Mixed results for tetramethylpyrazine nitrone treatment in ALS

1 month ago | medwirenews.com | Lucy Piper

By Lucy Piper, medwireNews ReportermedwireNews: Tetramethylpyrazine nitrone does not slow overall functional decline in patients with amyotrophic lateral sclerosis, but it may help retain grip strength and is well tolerated, suggest study findings. This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France. Read the full story on the L’Institut Servier websiteImage credit: © JuanCi Studio / stock.adobe.com
Quantifying high-risk chromosomal aberrations predicts multiple myeloma prognosis

2 months ago | medwirenews.com | Lynda Williams |Lucy Piper

By Lynda Williams, medwireNews ReportermedwireNews: The presence of two or more high-risk chromosomal aberrations in patients with multiple myeloma is associated with an especially poor outcome throughout the disease course, shows research published in the Journal of Clinical Oncology. This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France. Read the full story on the L’Institut Servier websiteImage credit: © luchschenF / stock.adobe.com
Cancer-related PE death increase shown in the USA

2 months ago | medwirenews.com | Lynda Williams |Lucy Piper

By Lynda Williams, medwireNews ReportermedwireNews: US study findings indicate that the incidence of pulmonary embolism-related death in people with cancer rose significantly between 2011 and 2020 despite an overall reduction in age-adjusted cancer diagnoses and cancer-related deaths over the period. This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.
Larotrectinib discontinuation possible for some paediatric NTRK fusion-positive tumours

2 months ago | medwirenews.com | Lynda Williams |Lucy Piper

By Lynda Williams, medwireNews ReportermedwireNews: Children who respond to larotrectinib therapy for sarcoma with a neurotrophic tyrosine receptor kinase gene fusion may be able to discontinue treatment, indicates research published in the Journal of Clinical Oncology. This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France. Read the full story on the L’Institut Servier websiteImage credit: © FatCamera / Getty Images / iStock